Situational panorama of chronic liver diseases: A single-center experience at a University Hospital in northeast Mexico (1995¿2019) Paula Cordero-Perez; Liliana Torres-González; Samuel Rivas-López; Carolina Treviño-García; Airam Regalado-Ceballos; Jaime R. Zúñiga-Noriega; Ingrid G. López-Reyna; Luz M. Barbosa-Castillo; Isai E. Hernández-Padilla; Linda E. Muñoz-Espinosa;

Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases Patrizia Burra; Calogero Cammà; Pietro Invernizzi; Fabio Marra; Maurizio Pompili;

Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial Do Seon Song; Jin Mo Yang; Young Kul Jung; Hyung Joon Yim; Hee Yeon Kim; Chang Wook Kim; Soon Sun Kim; Jae Youn Cheong; Hae Lim Lee; Sung Won Lee; Jeong-Ju Yoo; Sang Gyune Kim; Young Seok Kim;